I think the market has finally woken up to the Neuren story.On the announcement of the 14th of november 2016 the chairman Dr Richard Treagus said the company is looking forward to receiving the top line results for retts syndrome in march 2017and engaging with their clinical expert advisors and potential commercial partners to determine the optimum path to market for trofinetide in retts syndrome and other indications.In my opinion that says alot about the companys potential.
Has the market finally woken up to Neuren.
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.39 |
Change
-0.470(2.37%) |
Mkt cap ! $2.478B | |||
| Open | High | Low | Value | Volume |
| $19.70 | $19.77 | $19.28 | $10.38M | 534.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2680 | $19.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.41 | 362 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |